The Trans Tasman Radiation Oncology Group is an experienced research group conducting cancer clinical trials involving radiotherapy (RT) in order to improve cure rates, quality of life and to reduce side-effects of treatment. Fifty per cent of all cancer patients need RT as part of their treatment. The aim of the proposal is to strengthen the quality and safety of RT trials by (a) enabling rapid review and checking of treatment by electronic means and (b) improve trial design.
Australasian Leukaemia Lymphoma Group (ALLG) National Leukaemia And Lymphoma Tissue Bank (NLLTB)
Funder
National Health and Medical Research Council
Funding Amount
$2,106,750.00
Summary
Recent advances in knowledge about how cancer differ from normal cells, why some people are susceptible to cancer, and how new treatments can target cancer have all occurred through research on cancer cells from patients. To benefit patients with cancers of the blood and the immune system, we established a National Leukaemia and Lymphoma Tissue Bank in 2002. It is proposed to dramatically expand its size, add relevant clinical data, and streamline access and utility for Australian researchers. U ....Recent advances in knowledge about how cancer differ from normal cells, why some people are susceptible to cancer, and how new treatments can target cancer have all occurred through research on cancer cells from patients. To benefit patients with cancers of the blood and the immune system, we established a National Leukaemia and Lymphoma Tissue Bank in 2002. It is proposed to dramatically expand its size, add relevant clinical data, and streamline access and utility for Australian researchers. Ultimately, this will lead to better treatment and prevention of blood cancers.Read moreRead less